China Cybersecurity Reviews Signal New Regulatory Tightening Wave
Increasing cybersecurity reviews and the incoming Data Security Law are expected to affect companies collecting, processing and transferring data in China, and the impact is likely to go beyond its borders in relation to privacy protection and national security implications. But the health sector may be less affected than consumer services.
You may also be interested in...
Early study results show CanSino’s inhaled vaccine for COVID-19 triggered an immune response similar to its injected counterpart.
The US listing of Chinese artificial intelligence, medical records and patient management system company Linkdoc could be derailed, after China issued new data review requirements tightening the oversight of overseas listings of domestic companies.
Both Nasdaq- and Hong Kong-listed shares in Chinese health-related companies have been free falling with heavy volumes, after foreign investors spooked by China's general crackdown on the tech sector rushed to exit. The two-day sell-off shows high uncertainty and investors' anxiety over the regulatory overreach but underlying fundamentals still seem strong.